BioHealth News Archive
PhaseBio Pharmaceuticals Closes $48.4M Series B -peHUB
PhaseBio Pharmaceuticals Inc., a clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, has closed its Series B round with…
Read MoreMaryland entrepreneurs urge culture change – MDBIZNews
A panel of entrepreneurs told the Maryland Economic Development Commission on Tuesday that Maryland needs to commercialize more discoveries made in academic and government…
Read MoreShady Grove Office Center lands Tech Council of Maryland headquarters – Washington Business Journal
The Tech Council of Maryland has moved into its new headquarters in the Shady Grove Office Center, Citybizlist.com reports. The new location, at 9210…
Read MoreHHS harnesses the power of health data to improve health
The Department of Health and Human Services (HHS), along with the Institute of Medicine (IoM) and other members of the Health Data Consortium, are…
Read MoreTech Council of Maryland Moves Headquarters to New Rockville Office
The Tech Council of Maryland (TCM), Maryland's largest technology trade association with more than 400 biotechnology and technology members employing more than 200,000 in…
Read MoreMorning Read: VC sees opportunities in areas where Pharma is pulling back
Counter-intuitive as it may be, investing in areas that pharma is abandoning could yield great returns for investors. Just look at anti-bacterials in the…
Read MoreMaryland’s 18 Most Promising Incubator Companies – Citybizlist Baltimore
The 12th Annual Maryland Incubator Company of the Year Awards, supported by the Maryland Department of Business and Economic Development (DBED), the Maryland Technology…
Read MoreUMBC Incubator Gets New Cyber Security Firms
The incubator at University of Maryland, Baltimore County has gotten an influx of new tenants, the majority of whom are responding to the increased demand for cyber security. bwtech@UMBC Research…
Read MoreImmunomic Therapeutics’ CEO, Dr. William G. Hearl, to Present at 2012 BIO International in June
Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company with laboratories in Rockville, MD, announced that it has been accepted to present at the Business…
Read MoreImmunomic Therapeutics Receives IND Authorization from FDA for Phase I Study of Japanese Red Cedar LAMP-vax Vaccine
Immunomic Therapeutics, Inc., ("ITI," Lancaster, PA) a privately-held biotechnology company with laboratories in Rockville, MD, announced that the U.S. Food and Drug Administration (FDA)…
Read MoreMerck Looks to Startups – Technology Review
With pharmaceutical industry research budgets shrinking, large drug companies are instead looking to support early-stage biotechnology startups. Merck, Eli Lilly, and GlaxoSmithKline have all…
Read MoreCultural competency: A communication challenge for all | Washington Times Communities
Thousands upon thousands of brilliant, motivated, hard working—and legal—immigrants live in the United States. Every year additional highly educated professionals arrive to study and…
Read MoreAccelerator Looks to Expand, With an Eye on the Big Apple | Xconomy
Accelerator, the venture-backed biotech startup machine, has made its name over the past decade as a hotspot for financing life sciences companies in Seattle with…
Read MoreJudge sides with HGS on poison pill
The latest chapter in Human Genome Sciences’ battle to fend off a hostile takeover bid by British pharma giant GlaxoSmithKline played out in a…
Read MoreJohns Hopkins’ High Tech Hospital: Interview with President Ronald R. Peterson
Johns Hopkins has had many milestones since it first opened its hospital in Baltimore in 1889. It pioneered the acceptance of women to medical school and…
Read More